At the World Economic Forum in Davos, the creation of the Global Coalition for Epidemic Preparedness Innovations (Coalition for Epidemic Preparedness Innovations, CEPI) was announced. Governmental and non-governmental organizations from different countries, members of the coalition, in the near future will invest about $500 million on research and other activities designed to prevent the development of epidemics. First of all, this refers to creation of new vaccines against dangerous diseases that can cause epidemics and pandemics, states the website qz.com.
CEPI currently managed to raise $460 million from the governments of Norway, Japan, Germany and India, as well as the European Commission, Welcome Trust and Gates Foundation funds.
Coalition signed a memorandum of cooperation with the World Health Organization (WHO). The Alliance will use the list of priority threats, drafted by WHO experts to form plans for research work. The first targets will be the vaccine of the Middle East respiratory syndrome (MERS), Lassa fever and Nipah virus. Influenza vaccines, Dengue fever and Zika are not a priority in the alliance, because pharmaceutical companies are already actively working on them.
In addition, the alliance plans to seek new approaches to combat unknown viruses. In particular, it refers to the development of technologies to quickly identify the DNA of the virus and develop a vaccine against it.